 EX-10.20 7 nvls-20161231ex10200976d.htm EX-10.20
Exhibit 10.20

AMENDMENT to the
EMPLOYMENT AGREEMENT
between
Nivalis Therapeutics, Inc.
and
David M. Rodman, M.D. (“Employee”)
 
WHEREAS, Nivalis Therapeutics, Inc. (the “Company”) and the Employee 
entered into an employment agreement (the “Agreement”) effective as of 
April 18, 2016;
 
WHEREAS, the Company and the Employee desire to amend the Agreement to 
change the provision relating to accelerated vesting of stock options in 
connection with Termination/Severance;
 
NOW, THEREFORE, in consideration of the promises and mutual covenants 
contained herein and for other good and valuable consideration, the parties 
agree as follows:
 
     

1.

Section 5(e)(iii) is amended and restated in its entirety to read as 
follows:
        
       (iii)  the Company shall cause any issued but unvested options to
       vest in full and to cause any issued but unvested restricted stock
       units scheduled to vest in the twelve (12) months following
       Employee’s Termination Date to immediately vest; provided, however,
       that this sentence shall not diminish the 100% vesting contemplated
       by 5(g) below in connection with a Change of Control.
        

2.

Except as amended herein, the provisions of the Agreement shall remain in 
full force and effect.
 
IN WITNESS WHEREOF, the Company has caused this Amendment to be executed 
and Employee has hereunto set his hand as of January 12, 2017.
 
 
 
 
 
 
NIVALIS THERAPEUTICS, INC.
 
 
 
By:
/s/ R. Michael Carruthers
 
Name:
R. Michael Carruthers
 
Title:
Chief Financial Officer
 
Date:
1/12/17
 
 
 
 
 
EMPLOYEE
 
 
 
By:
/s/ David M. Rodman, M.D.
 
 
David M. Rodman, M.D.
 

------------------------------------------------------------------------